Advanced cancers: Eradication in all cases using 3-bromopyruvate therapy to deplete ATP

Biochemical and Biophysical Research Communications

Volumn 324, Issue 1, 2004, Pages 269-275

  Ko, Young H ^a   Smith, Barbara L ^a   Wang, Yuchuan ^a   Pomper, Martin G ^a   Rini, David A ^a   Torbenson, Michael S ^a   Hullihen, Joanne ^a   Pedersen, Peter L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

3 Bromopyruvic acid; Advanced cancers; ATP depletion; Cancer therapy; Liver colon cancer

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALKYLATING AGENT; BROMOPYRUVIC ACID; FLUORODEOXYGLUCOSE; PYRUVIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ADVANCED CANCER; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RECURRENCE; CARCINOMA CELL; CONTROLLED STUDY; ERADICATION THERAPY; GLYCOLYSIS; LIVER CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; RAT; TOXICITY;

ADENOSINE TRIPHOSPHATE; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; ENZYME INHIBITORS; FEMALE; GLUCOSE; HUMANS; LIVER NEOPLASMS, EXPERIMENTAL; NEOPLASM TRANSPLANTATION; PYRUVATES; RATS; RATS, SPRAGUE-DAWLEY; SURVIVAL RATE;

ANIMALIA;

EID: 4744341871     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.09.047     Document Type: Article

References (15)

1. J. Bruix, L. Boix, M. Sala, and J.M. Llovet Focus on hepatocellular carcinoma Cancer Cell 5 2004 215 219
2. O. Warburg The Metabolism of Tumors 1930 Arnold Constable London
3. P.L. Pedersen Tumor mitochondria and the bioenergetics of cancer cells Prog. Exp. Tumor Res. 22 1978 190 274
4. P.L. Pedersen, S. Mathupala, A. Rempel, J.F. Geschwind, and Y.H. Ko Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention Biochim. Biophys. Acta 1555 2002 14 20
5. S. Yasuda, S. Arii, A. Mori, N. Isobe, W. Yang, H. Oe, A. Fujimoto, Y. Yonenaga, H. Sakashita, and M. Imamura Hexokinase II and VEGF expression in liver tumors: correlation with hypoxia-inducible factor 1 alpha and its significance J. Hepatol. 40 2004 117 123
6. E.M. Rohren, T.G. Turkington, and R.E. Coleman Clinical applications of PET in oncology Radiology 231 2004 305 332
7. E. Bustamante, and P.L. Pedersen High aerobic glycolysis of rat hepatoma cells in culture: role of mitochondrial hexokinase Proc. Natl. Acad. Sci. USA 74 1977 3735 3739
8. D.F. Smith, E.F. Walborg Jr., and J.P. Chang Establishment of a transplantable ascites variant of a rat hepatoma induced by 3′-methyl-4- dimethylaminoazobenzene Cancer Res. 30 1970 2306 2309
9. K. Shimoji, L. Ravasi, K. Schmidt, M.L. Soto-Montenegro, T. Esaki, J. Seidel, E. Jagoda, L. Sokoloff, M.V. Green, and W.C. Eckelman Measurement of cerebral glucose metabolic rates in the anesthetized rat by dynamic scanning with 18F-FDG, the ATLAS small animal PET scanner, and arterial blood sampling J. Nucl. Med. 45 2004 665 672
10. S. Siegel, J.J. Vaquero, L. Aloj, J. Seidel, W.R. Gandler, and M.V. Green Initial results from a PET/planar small imaging system IEEE Trans. Nucl. Sci. 46 1999 571 575
11. R. Yao, J. Seidel, C.A. Johnson, M.E. Daube-Witherspoon, M.V. Green, and R.E. Carson Performance characteristics of the 3-D OSEM algorithm in the reconstruction of small animal PET images. Ordered-subsets expectation- maximization IEEE Trans. Med. Imaging 19 2000 798 804
12. R. Hebel, and M.W. Stromberg Anatomy of the Laboratory Rat 1976 Williams and Wilkins Baltimore
13. Y.H. Ko, and B.A. McFadden Alkylation of isocitrate lyase from Escherichia coli by 3-bromopyruvate Arch. Biochem. Biophys. 278 1990 373 380
14. Y.H. Ko, P.L. Pedersen, and J.F. Geschwind Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase Cancer Lett. 173 2001 83 91
15. J.F. Geschwind, Y.H. Ko, M.S. Torbenson, C. Magee, and P.L. Pedersen Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production Cancer Res. 62 2002 3909 3913